NYSE - Nasdaq Real Time Price USD

International Flavors & Fragrances Inc. (IFF)

75.00
-0.72
(-0.95%)
At close: May 23 at 4:00:02 PM EDT
76.78
+1.78
+(2.37%)
After hours: May 23 at 7:41:46 PM EDT
Loading Chart for IFF
  • Previous Close 75.72
  • Open 74.96
  • Bid 75.00 x 800
  • Ask 75.19 x 800
  • Day's Range 74.25 - 75.55
  • 52 Week Range 65.85 - 106.77
  • Volume 1,402,520
  • Avg. Volume 1,916,360
  • Market Cap (intraday) 19.184B
  • Beta (5Y Monthly) 1.10
  • PE Ratio (TTM) --
  • EPS (TTM) -3.26
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield 1.60 (2.13%)
  • Ex-Dividend Date Jun 20, 2025
  • 1y Target Est 91.61

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, pharma solutions, and complementary adjacent products in the United States, Europe, and internationally. It operates in four segments Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment consists of portfolio of natural-based ingredients that includes plant-based specialty food ingredients, such as soy and pea protein with value-added formulations, emulsifiers, and sweeteners; food protection ingredients, including natural antioxidants, and anti-microbials for natural food preservation and shelf-life extension; savory solutions, such as spices, marinades, and mixtures; combining flavourings with fruits, vegetables, and other natural ingredients products; a range of flavor compounds used in savory products, such as soups, sauces, meat, fish, poultry, and snacks; and beverages juice drinks, carbonated or flavored beverages, and spirits, as well as sweets bakery products, candy, cereal, and chewing gum; and dairy products, such as yogurt, ice cream, and cheese, as well as spices and seasoning ingredients. Its Health & Biosciences is comprised of health, cultures and food enzymes, home and personal care, animal nutrition, and grain processing. The Scent segment creates fragrance compounds, and fragrance ingredients. Its Pharma Solutions segment produces cellulosics and seaweed-based pharmaceutical excipients. The company was incorporated in 1909 and is headquartered in New York, New York.

www.iff.com

22,400

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IFF

View More

Performance Overview: IFF

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IFF
10.85%
S&P 500 (^GSPC)
1.34%

1-Year Return

IFF
19.19%
S&P 500 (^GSPC)
10.16%

3-Year Return

IFF
36.62%
S&P 500 (^GSPC)
46.03%

5-Year Return

IFF
33.65%
S&P 500 (^GSPC)
96.34%

Compare To: IFF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IFF

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    19.18B

  • Enterprise Value

    28.48B

  • Trailing P/E

    --

  • Forward P/E

    17.99

  • PEG Ratio (5yr expected)

    0.94

  • Price/Sales (ttm)

    1.68

  • Price/Book (mrq)

    1.46

  • Enterprise Value/Revenue

    2.49

  • Enterprise Value/EBITDA

    65.48

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.31%

  • Return on Assets (ttm)

    1.68%

  • Return on Equity (ttm)

    -6.03%

  • Revenue (ttm)

    11.43B

  • Net Income Avi to Common (ttm)

    -835M

  • Diluted EPS (ttm)

    -3.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    613M

  • Total Debt/Equity (mrq)

    75.01%

  • Levered Free Cash Flow (ttm)

    -1.26B

Research Analysis: IFF

View More

Company Insights: IFF

Research Reports: IFF

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.